MedTrace Logo

12 Weeks Orienteering Program Exercise on Older Adults

NCT05937009 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2023-12-05

No results posted yet for this study

Summary

This study aims to determine the effects of an orientation exercise program addressed to old on physical-motor, cognitive, and affective competencies.

This quasi-experimental study is a controlled trial involving an orientation exercise program. The program will run for 12 weeks (3 sessions per week).

Participants will be clustered into two groups: the experimental group will perform the exercise orientation sessions, and the control group will maintain regular activities routines. Evaluations will be performed before and after the intervention.

After the study is finished, the control group will attend a similar exercise program.

Conditions

  • Community-dwelling Older Adults

Interventions

OTHER

Orienteering exercise program

Orienteering exercise program running for 12 weeks (30-45 minutes, 3 sessions/week). Sessions will have 4 phases: 1) Signature of attendance sheet; 2) warm-up exercises for 5 minutes; 3) Start of orienteering proofs, where the departs will occur individually, with 3 interval minutes between participants; 4) stretches session, to return to a calm state.

Sponsors & Collaborators

  • University of Évora

    lead OTHER

Principal Investigators

  • Catarina Pereira, Doctoral degree · University of Évora

  • José Marmeleira, Doctoral degree · University of Évora

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-07-01
Completion
2024-01-01

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937009 on ClinicalTrials.gov